Mechanisms of T cell-mediated immune evasion in cervical cancer: a comprehensive bibliometric analysis and future research directions.
Cervical cancer, a prevalent malignancy caused by high-risk HPV strains, remains a significant challenge due to its ability to evade the immune system, particularly T cell-mediated responses.
APA
Bai X, Wang H, Guo Q (2026). Mechanisms of T cell-mediated immune evasion in cervical cancer: a comprehensive bibliometric analysis and future research directions.. Immunological medicine, 49(1), 1-21. https://doi.org/10.1080/25785826.2025.2560214
MLA
Bai X, et al.. "Mechanisms of T cell-mediated immune evasion in cervical cancer: a comprehensive bibliometric analysis and future research directions.." Immunological medicine, vol. 49, no. 1, 2026, pp. 1-21.
PMID
40970674
Abstract
Cervical cancer, a prevalent malignancy caused by high-risk HPV strains, remains a significant challenge due to its ability to evade the immune system, particularly T cell-mediated responses. This study aims to explore the research landscape surrounding T cell-mediated immune evasion in cervical cancer through a comprehensive bibliometric analysis. Using data from the Web of Science Core Collection (2014-2023), we employed VOSviewer, CiteSpace, and the R package "bibliometrics" to conduct co-citation and co-occurrence analyses, identifying key trends, contributors, and research hotspots. Our analysis included 930 studies from 68 countries, with China, the USA, and the Netherlands as the leading contributors. Emerging topics include immune checkpoint inhibitors, PD-L1, and tumor microenvironment modulation, highlighting the growing focus on immune-based therapies. This study provides valuable insights into the role of T cells in cervical cancer progression and offers a foundation for future research directions aimed at improving immunotherapy outcomes in cervical cancer patients.
MeSH Terms
Humans; Uterine Cervical Neoplasms; Female; Bibliometrics; T-Lymphocytes; Tumor Microenvironment; Tumor Escape; Immunotherapy; Immune Evasion; Immune Checkpoint Inhibitors
같은 제1저자의 인용 많은 논문 (5)
- Diagnostic performance of apparent diffusion coefficients for prostate cancer in patients with PI-RADS 4-5 lesions: a retrospective analysis.
- Targeting the ZDHHC9-mediated STAT1 palmitoylation-phosphorylation conversion inhibits gastric cancer progression.
- SMYD3 synergises with RACK1 to promote colorectal cancer lung metastasis by recruiting SMAD3.
- Macrophage membrane-encapsulated liposomes of protopanaxadiol-type doxorubicin hydrochloride improve formulation stability for the treatment of triple-negative breast cancer.
- Cost-Effectiveness Analysis of PI3K Inhibitors for Relapsed or Refractory Follicular Lymphoma in China: A Comparison Between Linperlisib and Duvelisib.